Charles River Laboratories International Inc (CRL) Moves -4.35% Lower: These Numbers are Too Good to be True

Witnessing the stock’s movement on the chart, on Wednesday, Charles River Laboratories International Inc (NYSE: CRL) had a quiet start as it plunged -4.35% to $206.54, before settling in for the price of $215.94 at the close. Taking a more long-term approach, CRL posted a 52-week range of $168.24-$275.00.

It was noted that the giant of the Healthcare sector posted annual sales growth of 12.89% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 14.84%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -4.71%. This publicly-traded company’s shares outstanding now amounts to $51.34 million, simultaneously with a float of $50.58 million. The organization now has a market capitalization sitting at $10.56 billion. At the time of writing, stock’s 50-day Moving Average stood at $195.15, while the 200-day Moving Average is $219.98.

Charles River Laboratories International Inc (CRL) Ownership Facts and Figures

Nothing is more important than checking the behaviour of major investors towards the stock of the Diagnostics & Research industry. Charles River Laboratories International Inc’s current insider ownership accounts for 1.10%, in contrast to 109.36% institutional ownership. According to the most recent insider trade that took place on Nov 07 ’24, this organization’s Director sold 6,621 shares at the rate of 216.12, making the entire transaction reach 1,430,918 in total value, affecting insider ownership by 12,386. Preceding that transaction, on Nov 07 ’24, Company’s Director sold 1,000 for 216.50, making the whole transaction’s value amount to 216,500. This particular insider is now the holder of 0 in total.

Charles River Laboratories International Inc (CRL) Earnings and Revenue Records

Charles River Laboratories International Inc’s EPS decrease for this current 12-month fiscal period is -4.71% and is forecasted to reach 10.35 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 4.06% through the next 5 years, which can be compared against the 14.84% growth it accomplished over the previous five years trading on the market.

Charles River Laboratories International Inc (NYSE: CRL) Trading Performance Indicators

Let’s observe the current performance indicators for Charles River Laboratories International Inc (CRL). It’s Quick Ratio in the last reported quarter now stands at 1.14. The Stock has managed to achieve an average true range (ATR) of 8.38. Alongside those numbers, its PE Ratio stands at $25.50, and its Beta score is 1.40. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.60. Similarly, its price to free cash flow for trailing twelve months is now 18.84.

In the same vein, CRL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 8.10, a figure that is expected to reach 2.54 in the next quarter, and analysts are predicting that it will be 10.35 at the market close of one year from today.

Technical Analysis of Charles River Laboratories International Inc (CRL)

Going through the that latest performance of [Charles River Laboratories International Inc, CRL]. Its last 5-days volume of 0.8 million indicated improvement to the volume of 0.62 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 69.95% While, its Average True Range was 9.30.

Raw Stochastic average of Charles River Laboratories International Inc (CRL) in the period of the previous 100 days is set at 38.70%, which indicates a major fall in contrast to 56.14% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 62.04% that was higher than 43.11% volatility it exhibited in the past 100-days period.